BR112014019167A8 - Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-los - Google Patents
Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-losInfo
- Publication number
- BR112014019167A8 BR112014019167A8 BR112014019167A BR112014019167A BR112014019167A8 BR 112014019167 A8 BR112014019167 A8 BR 112014019167A8 BR 112014019167 A BR112014019167 A BR 112014019167A BR 112014019167 A BR112014019167 A BR 112014019167A BR 112014019167 A8 BR112014019167 A8 BR 112014019167A8
- Authority
- BR
- Brazil
- Prior art keywords
- modulators
- cpt
- condition defined
- skin condition
- recurrence
- Prior art date
Links
- 208000035484 Cellulite Diseases 0.000 title abstract 6
- 206010049752 Peau d'orange Diseases 0.000 title abstract 6
- 230000036232 cellulite Effects 0.000 title abstract 6
- 150000002632 lipids Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 238000007920 subcutaneous administration Methods 0.000 title abstract 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title abstract 3
- 101000755720 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) Palmitoyltransferase akr1 Proteins 0.000 title abstract 3
- 229960004203 carnitine Drugs 0.000 title abstract 3
- 239000002537 cosmetic Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 101150073133 Cpt1a gene Proteins 0.000 title 1
- 230000003712 anti-aging effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261604631P | 2012-02-29 | 2012-02-29 | |
| PCT/US2013/027763 WO2013130446A1 (en) | 2012-02-29 | 2013-02-26 | Use of cpt-1 modulators and compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014019167A2 BR112014019167A2 (https=) | 2017-06-20 |
| BR112014019167A8 true BR112014019167A8 (pt) | 2017-07-11 |
Family
ID=49003123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014019167A BR112014019167A8 (pt) | 2012-02-29 | 2013-02-26 | Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-los |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130224318A1 (https=) |
| EP (1) | EP2819752A4 (https=) |
| JP (1) | JP2015511585A (https=) |
| CN (1) | CN104125848A (https=) |
| BR (1) | BR112014019167A8 (https=) |
| CA (1) | CA2863710A1 (https=) |
| MX (1) | MX2014009308A (https=) |
| WO (1) | WO2013130446A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2938992A1 (en) * | 2014-02-11 | 2015-08-20 | Elc Management Llc | Method, compositions, and kit for modulating the appearance of volume on keratin surfaces |
| TWI630922B (zh) | 2015-08-28 | 2018-08-01 | 康霈生技股份有限公司 | 用於減少局部脂肪的醫藥組成物及其用途 |
| US10085963B2 (en) * | 2015-11-10 | 2018-10-02 | Sami Labs Limited | Process and compositions for achieving mammalian energy balance |
| CN107064128B (zh) * | 2017-04-26 | 2020-01-17 | 浙江欣叶健康管理有限公司 | 一种尿液检测试剂及由其制备得到的尿液检测试纸 |
| CN107412095A (zh) * | 2017-05-17 | 2017-12-01 | 秀瑞斯(天津)科技有限公司 | 魔瘦纤体配方、制备方法及使用方法 |
| CN113260423B (zh) * | 2018-10-26 | 2024-10-29 | 伊万·加拉宁 | 促进体内最优皮肤白脂肪组织组合物的局部施用组合物和方法 |
| CN109925501A (zh) * | 2019-04-26 | 2019-06-25 | 贝亲母婴用品(上海)有限公司 | 一种用于改善皮肤屏障的组合物 |
| CN110604702B (zh) * | 2019-10-23 | 2025-09-12 | 碧豫药业有限责任公司 | 3-羟基-5-取代基苯甲酸在制备化妆品组合物或非治疗性皮肤处理组合物中的应用 |
| CN113116898A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE903646A (fr) * | 1985-11-14 | 1986-05-14 | Huysmans Guy A | Composition pour le traitement et l'entretien de la peau |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| US6071955A (en) * | 1999-02-25 | 2000-06-06 | The Regents Of The University Of California | FXR, PPARA and LXRA activators to treat acne/acneiform conditions |
| ITMI991894A1 (it) * | 1999-09-09 | 2001-03-09 | Carlo Ghisalberti | Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso |
| WO2001060331A2 (en) * | 2000-02-15 | 2001-08-23 | Zen-Bio, Inc. | Compositions for preventing cellulite in mammalian skin |
| US20030180395A1 (en) * | 2000-07-26 | 2003-09-25 | Bernd Bueter | Plant extract |
| JP4953512B2 (ja) * | 2001-02-13 | 2012-06-13 | 丸善製薬株式会社 | テストステロン5α−レダクターゼ阻害剤、アンドロゲン受容体結合阻害剤、抗男性ホルモン剤、頭髪化粧料、前立腺肥大抑制剤 |
| EP1234572B1 (de) * | 2001-02-26 | 2013-10-30 | Mibelle AG Cosmetics | Isoflavon-Aglykone enhaltende Hautbehandlungsmittel |
| KR100520408B1 (ko) * | 2003-03-25 | 2005-10-10 | 주식회사 태평양 | 비만개선용 조성물 |
| KR100998990B1 (ko) * | 2003-12-29 | 2010-12-09 | (주)아모레퍼시픽 | 슬리밍용 조성물 |
| JP2006524236A (ja) * | 2003-04-24 | 2006-10-26 | アモレパシフィック コーポレーション | スリミング用組成物 |
| US20090274777A1 (en) * | 2003-10-06 | 2009-11-05 | Hiroshi Shimoda | Dietetic composition |
| US20050186290A1 (en) * | 2003-12-10 | 2005-08-25 | L'oreal | Use of aquaglyceroporin modulators as slimming agent |
| JP4822718B2 (ja) * | 2005-03-16 | 2011-11-24 | 丸善製薬株式会社 | 新規c−グリコシド化合物、コラーゲン産生促進剤、皮膚化粧料及び美容用飲食品 |
| KR101314689B1 (ko) * | 2005-06-29 | 2013-10-07 | 디에스엠 아이피 어셋츠 비.브이. | 아이소플라본의 나노입자를 포함하는 국소용 조성물 |
| US20070088088A1 (en) * | 2005-10-18 | 2007-04-19 | Kissei Pharmaceutical Co., Ltd. | Method for preventing or treating metabolic syndrome |
| JP2008007406A (ja) * | 2006-05-29 | 2008-01-17 | Oriza Yuka Kk | 脂肪代謝促進剤 |
| EP1897530A1 (en) * | 2006-09-08 | 2008-03-12 | DSMIP Assets B.V. | Skin care composition |
| DE102007009650A1 (de) * | 2007-02-26 | 2008-08-28 | Beiersdorf Ag | Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes |
| KR20080105470A (ko) * | 2007-05-31 | 2008-12-04 | (주)아모레퍼시픽 | 인삼 열매 추출물을 함유하는 비만 예방 및 개선용 식품조성물 |
| KR101684871B1 (ko) * | 2009-11-30 | 2016-12-12 | (주)아모레퍼시픽 | 캡사이신 성분이 함유된 슬리밍용 화장료 조성물 |
| WO2011156136A1 (en) * | 2010-06-11 | 2011-12-15 | Avon Products, Inc. | Use of eclipta prostrata and other ppar-gamma inhibitors in cosmetics and compositions thereof |
| WO2012012509A1 (en) * | 2010-07-23 | 2012-01-26 | Johnson & Johnson Consumer Companies, Inc. | Corrosion current-generating metal particulates and use thereof |
| CN104125832A (zh) * | 2012-02-29 | 2014-10-29 | 雅芳产品公司 | 杨桃提取物作为cpt-1调节剂的用途及其组合物 |
-
2013
- 2013-02-26 EP EP13754739.4A patent/EP2819752A4/en not_active Withdrawn
- 2013-02-26 JP JP2014559944A patent/JP2015511585A/ja active Pending
- 2013-02-26 MX MX2014009308A patent/MX2014009308A/es unknown
- 2013-02-26 CA CA2863710A patent/CA2863710A1/en not_active Abandoned
- 2013-02-26 WO PCT/US2013/027763 patent/WO2013130446A1/en not_active Ceased
- 2013-02-26 US US13/777,288 patent/US20130224318A1/en not_active Abandoned
- 2013-02-26 CN CN201380010767.6A patent/CN104125848A/zh active Pending
- 2013-02-26 BR BR112014019167A patent/BR112014019167A8/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2819752A4 (en) | 2016-03-09 |
| WO2013130446A1 (en) | 2013-09-06 |
| CN104125848A (zh) | 2014-10-29 |
| EP2819752A1 (en) | 2015-01-07 |
| US20130224318A1 (en) | 2013-08-29 |
| CA2863710A1 (en) | 2013-09-06 |
| JP2015511585A (ja) | 2015-04-20 |
| MX2014009308A (es) | 2014-10-14 |
| BR112014019167A2 (https=) | 2017-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014019167A8 (pt) | Uso de moduladores da carnitina palmitoil transferase-1 (cpt-1) para tratar condição da pele definida por lipídios em excesso ou lipídios subcutâneos insuficientes e para reduzir a recorrência de celulite, bem como composições cosméticas compreendendo os referidos moduladores e método para identificá-los | |
| BR112015021033A8 (pt) | composição cosmética, métodos para regular ou prevenir uma condição de pele, para reduzir ou tratar sinais de envelhecimento de pele e para prevenir, clarear ou reduzir o aparecimento de descontinuidades visíveis da pele e usos de uma composição | |
| BR112014006455A2 (pt) | alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis | |
| BR112013018918A2 (pt) | composições de nanopartículas | |
| MX381518B (es) | Método cosmético para reducir las señales dermatológicas de envejecimiento. | |
| BR112013019519A2 (pt) | método de realce de crescimento capilar | |
| WO2012131623A3 (en) | Fractional cosmetic treatment process using a laser or microneedles | |
| BR112015008324A2 (pt) | método de aprimoramento de aparência de pele em envelhecimento através da modulação de wipi-1 | |
| MX2012013787A (es) | Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel. | |
| IN2015DN02938A (https=) | ||
| BR112014002595A2 (pt) | uso de esfinganina para melhorar a aparência visual da pele e cabelo | |
| BR112014023244A2 (pt) | método de tratamento de rugas usando agentes quimiodesenervantes tópicos | |
| MX2016003091A (es) | Composicion que comprende extracto de guacatonga y extracto de aroeira, uso de la misma para prevenir y/o tratar el envejecimiento de la piel. | |
| WO2012153064A3 (fr) | Composition cosmetique ou dermatologique a base d'extraits d'immortelle et son utilisation | |
| BR112012026875A2 (pt) | uso de eclipta prostrata e outros inibidores ppar-gamma em cosméticos e suas composições. | |
| BR112015010819A2 (pt) | ''composição de lavagem tópica, uso de composição e método para tratar ou melhorar a pele de indivíduos com acne'' | |
| IN2014DE01913A (https=) | ||
| MX2021010546A (es) | Composiciones y metodos para tratamiento de la piel. | |
| MX366410B (es) | Composiciones y metodos para tratamiento y reparacion de tendones. | |
| BR112017010710A2 (pt) | composição, especialmente uma composição cosmética, processo cosmético para tratar a pele e/ou as unhas e a perspiração e, opcionalmente, o odor corporal associado à perspiração humana e especialmente odor nas axilas e odor nos pés | |
| BR112015027224A8 (pt) | partículas compósitas, composição e processos cosméticos | |
| BRPI0918352A2 (pt) | composição cosmética antiperspirante, processo para a fabricação de uma composição e método de assentuar visualmente a aparência da pele e simultaneamente reduzir a perspiração em uma região localizada da pele | |
| BR112013003846A2 (pt) | métodos de tratamento de celulite | |
| BR112014019602A8 (pt) | Uso do extrato de carambola como um modulador de cpt1 e composições do mesmo | |
| BR112015017119A8 (pt) | composição cosmética, processos cosméticos não terapêuticos para cuidado e/ou maquilagem de uma matéria queratínica, para limitar o escurecimento da pele e para evitar e/ou tratar os sinais de envelhecimento e usos de uma composição cosmética |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2503 DE 26-12-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |